Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Venepalli NK"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Phase I study of procaspase-activating compound-1 (PAC-1) in the treatment of advanced malignancies.
Autor:
Danciu OC; Division of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA. ocdanciu@uic.edu.; Clinical Trials Office, University of Illinois Cancer Center, University of Illinois at Chicago, Chicago, IL, USA. ocdanciu@uic.edu., Holdhoff M; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA., Peterson RA; HealthPartners Institute, Regions Cancer Care Center, St. Paul, MN, USA., Fischer JH; Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA., Liu LC; Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, IL, USA., Wang H; Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, IL, USA., Venepalli NK; Division of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA., Chowdhery R; Division of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA., Nicholas MK; Division of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA., Russell MJ; Clinical Trials Office, University of Illinois Cancer Center, University of Illinois at Chicago, Chicago, IL, USA., Fan TM; Vanquish Oncology, Inc., Champaign, IL, USA.; Department of Veterinary Clinical Medicine, University of Illinois, Urbana-Champaign, IL, USA.; Cancer Center at Illinois, Urbana-Champaign, IL, USA.; Institute for Genomic Biology, University of Illinois, Urbana-Champaign, IL, USA., Hergenrother PJ; Vanquish Oncology, Inc., Champaign, IL, USA.; Cancer Center at Illinois, Urbana-Champaign, IL, USA.; Institute for Genomic Biology, University of Illinois, Urbana-Champaign, IL, USA.; Department of Chemistry, University of Illinois, Urbana-Champaign, IL, USA., Tarasow TM; Vanquish Oncology, Inc., Champaign, IL, USA., Dudek AZ; HealthPartners Institute, Regions Cancer Care Center, St. Paul, MN, USA.; Vanquish Oncology, Inc., Champaign, IL, USA.
Publikováno v:
British journal of cancer [Br J Cancer] 2023 Mar; Vol. 128 (5), pp. 783-792. Date of Electronic Publication: 2022 Dec 05.
Autor:
Fu J; Department of Internal Medicine, Hematology-Oncology, Tufts Medical Center Cancer Center, Stoneham, Massachusetts., Reid SA; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University, Nashville, Tennessee.; Vanderbilt-Ingram Cancer Center at Vanderbilt University Medical Center, Nashville, Tennessee., French B; Department of Biostatistics, Vanderbilt University, Nashville, Tennessee., Hennessy C; Department of Biostatistics, Vanderbilt University, Nashville, Tennessee., Hwang C; Department of Internal Medicine, Division of Hematology-Oncology, Henry Ford Cancer Institute, Detroit, Michigan., Gatson NT; Geisinger Health System, Danville, Danville, Pennsylvania.; Department of Cancer Medicine, Division of Neuro-Oncology, Banner MD Anderson Cancer Center, Gilbert, Arizona., Duma N; Division of Medical Oncology, Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts., Mishra S; Vanderbilt-Ingram Cancer Center at Vanderbilt University Medical Center, Nashville, Tennessee., Nguyen R; Department of Hematology and Oncology, University of Illinois, Chicago., Hawley JE; Herbert Irving Comprehensive Cancer Center at Columbia University, New York, New York.; Now with Division of Oncology, Fred Hutchinson Cancer Research Center, University of Washington, Seattle., Singh SRK; Department of Internal Medicine, Division of Hematology-Oncology, Henry Ford Cancer Institute, Detroit, Michigan., Chism DD; Thompson Cancer Survival Center, Knoxville, Tennessee., Venepalli NK; Division of Oncology, Department of Medicine, University of North Carolina, Chapel Hill., Warner JL; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University, Nashville, Tennessee.; Vanderbilt-Ingram Cancer Center at Vanderbilt University Medical Center, Nashville, Tennessee.; Department of Biomedical Informatics, Vanderbilt University, Nashville, Tennessee., Choueiri TK; Division of Medical Oncology, Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts., Schmidt AL; Division of Medical Oncology, Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts., Fecher LA; Rogel Cancer Center, University of Michigan, Ann Arbor., Girard JE; Rogel Cancer Center, University of Michigan, Ann Arbor., Bilen MA; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia., Ravindranathan D; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia., Goyal S; Department of Radiation Oncology, George Washington University, Washington, DC., Wise-Draper TM; Department of Internal Medicine, Division of Hematology-Oncology, University of Cincinnati Cancer Center, Cincinnati, Ohio., Park C; Department of Hematology-Oncology, University of California, Davis., Painter CA; Count Me In, Broad Institute of MIT and Harvard, Cambridge, Massachusetts., McGlown SM; Patient advocate., de Lima Lopes G Jr; Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, Miami, Florida., Serrano OK; Department of Surgery, Hartford HealthCare Cancer Institute, Hartford, Connecticut., Shah DP; Population Health Sciences, Mays Cancer Center at University of Texas Health San Antonio MD Anderson, San Antonio.
Publikováno v:
JAMA network open [JAMA Netw Open] 2022 Mar 01; Vol. 5 (3), pp. e224304. Date of Electronic Publication: 2022 Mar 01.
Autor:
Hawley JE; Herbert Irving Comprehensive Cancer Center at Columbia University, New York, New York.; now with Division of Oncology, University of Washington/Fred Hutchinson Cancer Research Center, Seattle., Sun T; Vanderbilt University Medical Center, Nashville, Tennessee., Chism DD; Thompson Cancer Survival Center, Knoxville, Tennessee., Duma N; University of Wisconsin Carbone Cancer Center, Madison., Fu JC; Tufts Medical Center Cancer Center, Boston and Stoneham, Massachusetts., Gatson NTN; Geisinger Health System, Danville, Pennsylvania.; Banner MD Anderson Cancer Center, Gilbert, Arizona., Mishra S; Vanderbilt University Medical Center, Nashville, Tennessee., Nguyen RH; University of Illinois Hospital & Health Sciences System, Chicago., Reid SA; Vanderbilt University Medical Center, Nashville, Tennessee., Serrano OK; Hartford HealthCare Cancer Institute, Hartford, Connecticut., Singh SRK; Henry Ford Cancer Institute, Henry Ford Hospital, Detroit, Michigan., Venepalli NK; University of North Carolina, Lineberger Cancer Center, Chapel Hill., Bakouny Z; Dana-Farber Cancer Institute, Boston, Massachusetts., Bashir B; Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania., Bilen MA; Winship Cancer Institute of Emory University, Atlanta, Georgia., Caimi PF; Case Comprehensive Cancer Center at Case Western Reserve University/University Hospitals, Cleveland, Ohio., Choueiri TK; Dana-Farber Cancer Institute, Boston, Massachusetts., Dawsey SJ; Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio., Fecher LA; University of Michigan Rogel Cancer Center, Ann Arbor., Flora DB; St Elizabeth Healthcare, Edgewood, Kentucky., Friese CR; University of Michigan Rogel Cancer Center, Ann Arbor., Glover MJ; Stanford Cancer Institute at Stanford University, Palo Alto, California., Gonzalez CJ; University of Michigan Rogel Cancer Center, Ann Arbor., Goyal S; George Washington University, Washington, DC., Halfdanarson TR; Mayo Clinic, Rochester, Minnesota., Hershman DL; Herbert Irving Comprehensive Cancer Center at Columbia University, New York, New York., Khan H; Brown University and Lifespan Cancer Institute, Providence, Rhode Island., Labaki C; Dana-Farber Cancer Institute, Boston, Massachusetts., Lewis MA; Intermountain Healthcare, Salt Lake City, Utah., McKay RR; University of California, San Diego., Messing I; George Washington University, Washington, DC., Pennell NA; Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio., Puc M; Virtua Health, Marlton, New Jersey., Ravindranathan D; Winship Cancer Institute of Emory University, Atlanta, Georgia., Rhodes TD; Intermountain Healthcare, Salt Lake City, Utah., Rivera AV; Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania., Roller J; University of Kansas Medical Center, Kansas City., Schwartz GK; Herbert Irving Comprehensive Cancer Center at Columbia University, New York, New York., Shah SA; Stanford Cancer Institute at Stanford University, Palo Alto, California., Shaya JA; University of California, San Diego., Streckfuss M; Advocate Aurora Health, Milwaukee, Wisconsin., Thompson MA; Advocate Aurora Health, Milwaukee, Wisconsin., Wulff-Burchfield EM; University of Kansas Medical Center, Kansas City., Xie Z; Mayo Clinic, Rochester, Minnesota., Yu PP; Hartford HealthCare Cancer Institute, Hartford, Connecticut., Warner JL; Vanderbilt University Medical Center, Nashville, Tennessee., Shah DP; Mays Cancer Center at UT Health San Antonio MD Anderson Cancer Center, San Antonio, Texas., French B; Vanderbilt University Medical Center, Nashville, Tennessee., Hwang C; Henry Ford Cancer Institute, Henry Ford Hospital, Detroit, Michigan.
Publikováno v:
JAMA network open [JAMA Netw Open] 2022 Jan 04; Vol. 5 (1), pp. e2142046. Date of Electronic Publication: 2022 Jan 04.
Autor:
Apisarnthanarax S; Department of Radiation Oncology, University of Washington, Seattle, Washington. Electronic address: apisarn@uw.edu., Barry A; Department of Radiation Oncology, Princess Margaret Cancer Center, Toronto, Ontario, Canada., Cao M; Department of Radiation Oncology, University of California, Los Angeles, California., Czito B; Department of Radiation Oncology, Duke University, Durham, North Carolina., DeMatteo R; Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania., Drinane M; Department of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire., Hallemeier CL; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Koay EJ; Department of Radiation Oncology, UT-MD Anderson Cancer Center, Houston, Texas., Lasley F; Department of Radiation Oncology, GenesisCare, Rogers, Arkansas., Meyer J; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, Maryland., Owen D; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Pursley J; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts., Schaub SK; Department of Radiation Oncology, University of Washington, Seattle, Washington., Smith G; Department of Radiation Oncology, UT-MD Anderson Cancer Center, Houston, Texas., Venepalli NK; Department of Medicine, University of North Carolina, Chapel Hill, North Carolina., Zibari G; Department of Transplantation Services, Willis-Knighton Medical Center, Shreveport, Louisiana., Cardenes H; Department of Radiation Oncology, Weill Cornell, New York, New York.
Publikováno v:
Practical radiation oncology [Pract Radiat Oncol] 2022 Jan-Feb; Vol. 12 (1), pp. 28-51. Date of Electronic Publication: 2021 Oct 21.
Autor:
Schorer AE; Oncology Analytics, Atlanta, GA., Moldwin R; College of American Pathologists, Northfield, IL., Koskimaki J; CancerLinQ, American Society of Clinical Oncology, Alexandria, VA., Bernstam EV; The University of Texas School of Biomedical Informatics at Houston and Division of General Internal Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, TX., Venepalli NK; Department of Medicine, The University of Illinois, Chicago, IL., Miller RS; CancerLinQ, American Society of Clinical Oncology, Alexandria, VA., Chen JL; Departments of Internal Medicine and Biomedical Informatics, The Ohio State University, Columbus, OH.
Publikováno v:
JCO clinical cancer informatics [JCO Clin Cancer Inform] 2022 Jan; Vol. 6, pp. e2100128.
Autor:
Rubinstein SM; University of North Carolina at Chapel Hill, Chapel Hill, NC., Sethi T; Yale University, New Haven, CT., Venepalli NK; University of Illinois at Chicago College of Medicine, Chicago, IL., Gyawali B; Queens University, Kingston, Ontario, Canada., Schwartz C; University of Illinois at Chicago College of Medicine, Chicago, IL., Rivera DR; Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD., Yang PC; Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Warner JL; Vanderbilt University Medical Center, Nashville, TN.
Publikováno v:
JCO clinical cancer informatics [JCO Clin Cancer Inform] 2021 Jan; Vol. 5, pp. 30-35.
Autor:
Gordan JD; University of California, San Francisco, San Francisco, CA., Kennedy EB; American Society of Clinical Oncology, Alexandria, VA., Abou-Alfa GK; Memorial Sloan Kettering Cancer Center, Weill Medical College at Cornell University, New York, NY., Beg MS; UT Southwestern, Dallas, TX., Brower ST; Lefcourt Family Cancer Treatment and Wellness Center, Englewood, NJ., Gade TP; Penn Medicine, Philadelphia, PA., Goff L; Vanderbilt Ingram Cancer Center, Nashville, TN., Gupta S; Weill Cornell Medicine, New York, NY., Guy J; Sutter Health, San Francisco, CA., Harris WP; UW Medicine, Seattle, WA., Iyer R; Roswell Park Comprehensive Cancer Center, Buffalo, NY., Jaiyesimi I; Beaumont Hospital, Royal Oak, MI., Jhawer M; Englewood Hospital, Englewood, NJ., Karippot A; Cancer Treatment Centers of America, Tulsa, OK., Kaseb AO; MD Anderson Cancer Center, Houston, TX., Kelley RK; University of California, San Francisco, San Francisco, CA., Knox JJ; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Kortmansky J; Yale Cancer Center, New Haven, CT., Leaf A; VA New York Harbor Healthcare System, Brooklyn, NY., Remak WM; California Hepatitis C Task Force, California Chronic Care Coalition, FAIR Foundation, San Francisco, CA., Shroff RT; University of Arizona Cancer Center, Tucson, AZ., Sohal DPS; University of Cincinnati, Cincinnati, OH., Taddei TH; Yale University School of Medicine and VA Connecticut Healthcare System, West Haven, CT., Venepalli NK; University of Illinois Hospital, Chicago, IL., Wilson A; Blue Faery: The Adrienne Wilson Liver Cancer Association, Birmingham, AL., Zhu AX; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Rose MG; Yale Cancer Center and VA Connecticut Healthcare System, West Haven, CT.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Dec 20; Vol. 38 (36), pp. 4317-4345. Date of Electronic Publication: 2020 Nov 16.
Autor:
Li X; Vanderbilt University, Nashville, TN, USA., Sigworth EA; Vanderbilt University, Nashville, TN, USA., Wu AH; Mount Holyoke College, South Hadley, MA, USA., Behrens J; Vanderbilt University, Nashville, TN, USA., Etemad SA; Vanderbilt University, Nashville, TN, USA., Nagpal S; Stanford University, Palo Alto, CA, USA., Go RS; Mayo Clinic, Rochester, MN, USA., Wuichet K; Vanderbilt University Medical Center, 2220 Pierce Ave, PRB 777, Nashville, TN, 37232, USA., Chen EJ; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Rubinstein SM; Vanderbilt University Medical Center, 2220 Pierce Ave, PRB 777, Nashville, TN, 37232, USA., Venepalli NK; University of Illinois at Chicago, Chicago, IL, USA., Tillman BF; Vanderbilt University Medical Center, 2220 Pierce Ave, PRB 777, Nashville, TN, 37232, USA., Cowan AJ; University of Washington, Seattle, WA, USA., Schoen MW; Saint Louis University, St. Louis, MO, USA., Malty A; Stanford University, Palo Alto, CA, USA., Greer JP; Vanderbilt University Medical Center, 2220 Pierce Ave, PRB 777, Nashville, TN, 37232, USA., Fernandes HD; University of North Dakota, Grand Forks, ND, USA., Seifter A; University of Illinois at Chicago, Chicago, IL, USA., Chen Q; Vanderbilt University, Nashville, TN, USA., Chowdhery RA; University of Illinois at Chicago, Chicago, IL, USA., Mohan SR; Vanderbilt University Medical Center, 2220 Pierce Ave, PRB 777, Nashville, TN, 37232, USA., Dewdney SB; Rush University, Chicago, IL, USA., Osterman T; Vanderbilt University Medical Center, 2220 Pierce Ave, PRB 777, Nashville, TN, 37232, USA., Ambinder EP; Mount Sinai Medical Center, New York, NY, USA., Buchbinder EI; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Schwartz C; University of Illinois at Chicago, Chicago, IL, USA., Abraham I; University of Illinois at Chicago, Chicago, IL, USA., Rioth MJ; University of Colorado, Denver, CO, USA., Singh N; University of Illinois at Chicago, Chicago, IL, USA., Sharma S; Sequoia Regional Cancer Center, Visalia, CA, USA., Gibson MK; Vanderbilt University Medical Center, 2220 Pierce Ave, PRB 777, Nashville, TN, 37232, USA., Yang PC; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Warner JL; Vanderbilt University Medical Center, 2220 Pierce Ave, PRB 777, Nashville, TN, 37232, USA. jeremy.warner@vumc.org.
Publikováno v:
Scientific reports [Sci Rep] 2020 Oct 16; Vol. 10 (1), pp. 17536. Date of Electronic Publication: 2020 Oct 16.
Autor:
Kang S; Division of Internal Medicine, University of Illinois at Chicago, Chicago, IL, USA., Zaidi AJ; Oncology Clinical Trials Office, University of Illinois at Chicago, Chicago, IL, USA., Shokouh-Amiri M; Department of Pathology, University of Illinois at Chicago, Chicago, IL, USA., Wiley E; Department of Pathology, University of Illinois at Chicago, Chicago, IL, USA., Venepalli NK; Division of Hematology Oncology, Department of Medicine Oncology, University of Illinois at Chicago, Chicago, IL, USA.
Publikováno v:
Journal of gastrointestinal oncology [J Gastrointest Oncol] 2019 Dec; Vol. 10 (6), pp. 1151-1156.